相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum Vascular Endothelial Growth Factor Levels Lack Predictive Value in Patients with Active Ankylosing Spondylitis Treated with Golimumab
Jurgen Braun et al.
JOURNAL OF RHEUMATOLOGY (2016)
Systematic review: New serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes
J. Bonneau et al.
AUTOIMMUNITY REVIEWS (2015)
Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis
Smriti K. Raychaudhuri et al.
CLINICAL RHEUMATOLOGY (2015)
Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery
Emily K. Wright et al.
GASTROENTEROLOGY (2015)
Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients
Fernanda Genre et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study
R. Landewe et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis
X. Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Autoantibodies against CD74 in spondyloarthritis
N. T. Baerlecken et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis
Denis Poddubnyy et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Decreases in diagnostic delay are supported by sensitivity analyses
J. Sorensen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis
Maureen C. Turina et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome
H. El-Hadidi et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
High Serum Vaspin Concentrations in Patients with Ulcerative Colitis
Tomohito Morisaki et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Assessment of Lipocalin 2, Clusterin, Soluble Tumor Necrosis Factor Receptor-1, Interleukin-6, Homocysteine, and Uric Acid Levels in Patients with Psoriasis
Arzu Ataseven et al.
DISEASE MARKERS (2014)
Meta-analysis: Fecal Calprotectin for Assessment of Inflammatory Bowel Disease Activity
Jin-Feng Lin et al.
INFLAMMATORY BOWEL DISEASES (2014)
Evaluation of circulating levels of inflammatory and bone formation markers in axial spondyloarthritis
Kenia Rodrigues de Andrade et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Serum Vascular Endothelial Growth Factor, Transforming Growth Factor β1, and Nitric Oxide Levels in Patients With Psoriasis Vulgaris: Their Correlation to Disease Severity
Abdel-Raheim M. A. Meki et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2014)
Neutrophil gelatinase-associated lipocalin in blood in children with inflammatory bowel disease
Roman M. Janas et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Serum Leptin and Adiponectin Levels in Korean Patients with Psoriasis
Yu Jin Oh et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2014)
Biomarkers of Bone Metabolism in Ankylosing Spondylitis in Relation to Osteoproliferation and Osteoporosis
Eva Klingberg et al.
JOURNAL OF RHEUMATOLOGY (2014)
C- reactive protein in psoriasis: a review of the literature
S. Beygi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor
Leyla Didem Kozaci et al.
Modern Rheumatology (2014)
The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease
Kaija-Leena Kolho et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease
Bulent Yilmaz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Metabolic Changes and Serum Ghrelin Level in Patients with Psoriasis
Haydar Ucak et al.
DERMATOLOGY RESEARCH AND PRACTICE (2014)
Antimicrobial Proteins in Intestine and Inflammatory Bowel Diseases
Jung Mogg Kim
INTESTINAL RESEARCH (2014)
Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
Joachim Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model
Liesbet Van Praet et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis
Jacqueline E. Paramarta et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI
Jorge Romani et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2013)
Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?
Dominique Baeten et al.
ARTHRITIS AND RHEUMATISM (2013)
High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage
Mariusz Korkosz et al.
BMC MUSCULOSKELETAL DISORDERS (2013)
Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab
P. Gisondi et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Serum lipid profile in psoriatic patients: correlation between vascular adhesion protein 1 and lipoprotein (a)
Houshang Nemati et al.
CELL BIOCHEMISTRY AND FUNCTION (2013)
Leptin levels in patients with psoriasis: a meta-analysis
K. -J. Zhu et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2013)
The Effect of Acitretin Treatment on Insulin Resistance, Retinol-Binding Protein-4, Leptin, and Adiponectin in Psoriasis Vulgaris: A Noncontrolled Study
Ayse Serap Karadag et al.
DERMATOLOGY (2013)
Relationship Between Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels and Inflammatory Bowel Disease Type and Activity
Atakan Yesil et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
S100A8-S100A9 Protein Complex Mediates Psoriasis by Regulating the Expression of Complement Factor C3
Helia B. Schonthaler et al.
IMMUNITY (2013)
Serum calprotectin as a biomarker for Crohn's disease
M.-A. Meuwis et al.
Journal of Crohns & Colitis (2013)
Serological markers of inflammatory bowel disease
Andrea Tesija Kuna
BIOCHEMIA MEDICA (2013)
High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis
Gisela Ruiz Heiland et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Serum levels of antimicrobial peptides and proteins do not correlate with psoriasis severity and are increased after treatment with fumaric acid esters
T. Gambichler et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2012)
Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human β2-microglobulin-transgenic rat model of spondylarthritis
Leonie M. van Duivenvoorde et al.
ARTHRITIS AND RHEUMATISM (2012)
Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis
Ali Taylan et al.
BMC MUSCULOSKELETAL DISORDERS (2012)
Serum lipocalin-2 levels are increased in patients with psoriasis
M. Kamata et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2012)
Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease
V. S. Rodrigues et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Serological antibodies in inflammatory bowel disease: A systematic review
Lani Prideaux et al.
INFLAMMATORY BOWEL DISEASES (2012)
High-sensitivity C-reactive protein in psoriasis
Nuzhatun Nisa et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2012)
Serum leptin, adiponectin, resistin and ghrelin levels in psoriatic patients treated with cyclosporin
Mustafa Ozdemir et al.
JOURNAL OF DERMATOLOGY (2012)
Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity
K. A. Oikonomou et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations
I. Flisiak et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Detection of Multiple Autoantibodies in Patients with Ankylosing Spondylitis Using Nucleic Acid Programmable Protein Arrays
Cynthia Wright et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Increased Frequencies of Th22 Cells as well as Th17 Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis and Rheumatoid Arthritis
Lei Zhang et al.
PLOS ONE (2012)
Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy
Seong-Ryul Kwon et al.
RHEUMATOLOGY INTERNATIONAL (2012)
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis
Denis Poddubnyy et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: A study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover
Susanne Juhl Pedersen et al.
ARTHRITIS AND RHEUMATISM (2011)
Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
Matthias Jurgens et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study
Gian Luca Erre et al.
CLINICAL RHEUMATOLOGY (2011)
New IBD genetics: common pathways with other diseases
C. W. Lees et al.
GUT (2011)
Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: Association with other clinical and laboratory parameters
Adam Kemeny-Beke et al.
JOINT BONE SPINE (2011)
The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
Paola Di Meglio et al.
PLOS ONE (2011)
Phototherapy reduces serum resistin levels in psoriasis patients
Kana Kawashima et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2011)
Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+and CD8+human T-cell functional responses
Ritu Sarin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels
Anssi Hamalainen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response
Heiner Appel et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Additional benefit of procalcitonin to C-reactive protein to assess disease activity and severity in Crohn's disease
A. Oussalah et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis
Lode Melis et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis
D. A. Poddubnyy et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome
Anastassios C. Manolakis et al.
BMC GASTROENTEROLOGY (2010)
Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy
S. Coimbra et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Serum cytokines and growth factor levels in Japanese patients with psoriasis
H. Takahashi et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2010)
Anti-agalactosyl IgG antibody in ankylosing spondylitis and psoriatic arthritis
Chen-Liang Chou et al.
CLINICAL RHEUMATOLOGY (2010)
Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors
Susanne Juhl Pedersen et al.
CLINICAL RHEUMATOLOGY (2010)
New Serologic Markers for Inflammatory Bowel Disease Diagnosis
Iris Dotan
DIGESTIVE DISEASES (2010)
Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity
Marko Brinar et al.
GUT (2010)
World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010
Charles N. Bernstein et al.
INFLAMMATORY BOWEL DISEASES (2010)
Circulating Levels of Chemerin and Adiponectin Are Higher in Ulcerative Colitis and Chemerin Is Elevated in Crohn's Disease
Johanna Weigert et al.
INFLAMMATORY BOWEL DISEASES (2010)
C-REACTIVE PROTEIN AND MARKERS FOR THROMBOPHILIA IN PATIENTS WITH CHRONIC PLAQUE PSORIASIS
P. Gisondi et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2010)
Fetuin-A and interleukin-18 levels in ankylosing spondylitis
Ismail Sari et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2010)
Effect of Narrow-band UVB Phototherapy on Soluble Cell Adhesion Molecules in Patients with Psoriasis Vulgaris
J. W. Long et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
pANCA, ASCA, and OmpC Antibodies in Patients with Ankylosing Spondylitis without Inflammatory Bowel Disease
Miriam de Vries et al.
JOURNAL OF RHEUMATOLOGY (2010)
C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy
S. Coimbra et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy
S. Coimbra et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci
John D. Reveille et al.
NATURE GENETICS (2010)
Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein
Mathilde Benhamou et al.
RHEUMATOLOGY (2010)
Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: Calprotectin and IL-6 changes do not correspond to sRAGE changes
Karin Malickova et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)
Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value
Evgenija Homsak et al.
WIENER KLINISCHE WOCHENSCHRIFT (2010)
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
Patrick F. van Rheenen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Does plasma resistin level have a role in predicting inflammatory bowel disease activity?
N. Kader et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2010)
Increased plasma ghrelin following infliximab in Crohn's disease
E. Z. H. Sung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
J. Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Altered Skeletal Expression of Sclerostin and Its Link to Radiographic Progression in Ankylosing Spondylitis
Heiner Appel et al.
ARTHRITIS AND RHEUMATISM (2009)
HLA-B27 Misfolding and the Unfolded Protein Response Augment Interleukin-23 Production and Are Associated With Th17 Activation in Transgenic Rats
Monica L. Delay et al.
ARTHRITIS AND RHEUMATISM (2009)
Erythrocyte Sedimentation Rate, C-Reactive Protein Level, and Serum Amyloid A Protein for Patient Selection and Monitoring of Anti-Tumor Necrosis Factor Treatment in Ankylosing Spondylitis
Mirjam K. de Vries et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Investigating the genetic association between ERAP1 and ankylosing spondylitis
David Harvey et al.
HUMAN MOLECULAR GENETICS (2009)
Concentrations of alpha- and beta-defensins in plasma of patients with inflammatory bowel disease
N. Yamaguchi et al.
INFLAMMATION RESEARCH (2009)
Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial
M. Caproni et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
Serum high molecular weight adiponectin levels are decreased in psoriasis patients
Sayaka Shibata et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2009)
β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin
Patrick A. M. Jansen et al.
PLOS ONE (2009)
Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease
Carlo Salvarani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Soluble intercellular adhesion molecule-1, D-lactate and diamine oxidase in patients with inflammatory bowel disease
Wei-Bing Song et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation
A. Johnston et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis
B. Strober et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-β induction via X-box binding protein 1
Judith A. Smith et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease
Yusuf Erzin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Leptin, adiponectin, resistin, and ghrelin - Implications for inflammatory bowel disease
Konstantinos Karmiris et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease
Michael Wagner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab
S. Visvanathan et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies:: a reassessment
S. Z. Aydin et al.
RHEUMATOLOGY (2008)
Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status
Yuksel Ates et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Serum interleukin-6, soluble interleukin-6 receptor and Crohn's disease activity
Stephane Nancey et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Nitric oxide levels in plasma and fibroblast cultures of psoriasis vulgaris patients
Anna Zalewska et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2007)
Resistin is an inflammatory marker of inflammatory bowel disease in humans
Astrid Konrad et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel disease
Konstantinos Karmiris et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice
Bert Vander Cruyssen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Tumour necrosis factor α (TNF-α)-converting enzyme (TACE) and soluble TNF-α receptor type 1 in psoriasis patients treated with narrowband ultraviolet B
Agnieszka Beata Serwin et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2007)
Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis
Walter P. Maksymowych et al.
ARTHRITIS AND RHEUMATISM (2007)
IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease
Mark Tremelling et al.
GASTROENTEROLOGY (2007)
Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy
Alexander C. von Roon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Dickkopf-1 is a master regulator of joint remodeling
Danielle Diarra et al.
NATURE MEDICINE (2007)
Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease
Steven T. Leach et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients
A. Madej et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2007)
Selenium supplementation, soluble tumor necrosis factor-α receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B
Agnieszka Beata Serwin et al.
NUTRITION (2006)
Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease
Patrick Chamouard et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis
Elli Kruithof et al.
ARTHRITIS AND RHEUMATISM (2006)
Additional human β2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats
TM Tran et al.
ARTHRITIS AND RHEUMATISM (2006)
Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity
CH Chen et al.
RHEUMATOLOGY (2006)
Circulating ghrelin levels in patients with inflammatory bowel disease
M Peracchi et al.
GUT (2006)
Plasma and scales levels of interleukin 18 in comparison with other possible clinical and laboratory biomarkers of psoriasis activity
I Flisiak et al.
BIOMARKERS (2006)
Serologic markers in inflammatory bowel disease
X Bossuyt
CLINICAL CHEMISTRY (2006)
Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease
K Karmiris et al.
INFLAMMATORY BOWEL DISEASES (2006)
High positive predictive value of specific antibodies cross-reacting with a 28-kDa Drosophila antigen for diagnosis of ankylosing spondylitis
C Duftner et al.
RHEUMATOLOGY (2006)
Nitric oxide levels in patients with psoriasis treated with methotrexate
Nilgun Solak Tekin et al.
MEDIATORS OF INFLAMMATION (2006)
Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity
O Arican et al.
MEDIATORS OF INFLAMMATION (2005)
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease
CA Solem et al.
INFLAMMATORY BOWEL DISEASES (2005)
Impact of infliximab on serum leptin levels in patients with Crohn's disease
D Franchimont et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Differential expression and response to anti-TNFα treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis
L De Rycke et al.
JOURNAL OF PATHOLOGY (2005)
Profile of soluble cytokine receptors in Crohn's disease
T Gustot et al.
GUT (2005)
Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis
KR Herrlinger et al.
INFLAMMATORY BOWEL DISEASES (2004)
Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis
S Ozgocmen et al.
RHEUMATOLOGY INTERNATIONAL (2004)
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor α blockade in spondylarthropathy
B Vandooren et al.
ARTHRITIS AND RHEUMATISM (2004)
Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease
BRK Smith et al.
INFLAMMATORY BOWEL DISEASES (2004)
Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology - A prospective study in 154 consecutive patients
D Baeten et al.
ARTHRITIS AND RHEUMATISM (2004)
Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease
F Magro et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors
S Kollnberger et al.
JOURNAL OF IMMUNOLOGY (2004)
Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms
J Balding et al.
MEDIATORS OF INFLAMMATION (2004)
Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis
CH Yang et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
The inflammatory response in mild and in severe psoriasis
P Rocha-Pereira et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis
D Kane et al.
ARTHRITIS AND RHEUMATISM (2003)
Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy
IEA Hoffman et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies
M Drouart et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Increased expression of interleukin 17 in inflammatory bowel disease
S Fujino et al.
GUT (2003)
Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease
I Vind et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations
S Gangemi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2003)
Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial
J Braun et al.
LANCET (2002)
A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders
AP Poullis et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy
F Van den Bosch et al.
ARTHRITIS AND RHEUMATISM (2002)
Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop
VG De Gruttola et al.
CONTROLLED CLINICAL TRIALS (2001)
Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease
WJ Sandborn et al.
INFLAMMATORY BOWEL DISEASES (2001)
Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity
D Baeten et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
PJ Mease et al.
LANCET (2000)
分享论文
